Association between Serum Cystatin C and Diabetic Foot Ulceration in Patients with Type 2 Diabetes: A Cross-Sectional Study

Journal of Diabetes Research

Volumn 2016, Issue , 2016, Pages

  Zhao, Jie ^a   Deng, Wuquan ^a   Zhang, Yuping ^a   Zheng, Yanling ^a   Zhou, Lina ^a   Boey, Johnson ^b   Armstrong, David G ^c   Yang, Gangyi ^d   Liang, Ziwen ^a   Chen, Bing ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

^c UNIVERSITY OF ARIZONA   (United States)

^d CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTATIN C; INSULIN;

ADULT; AGED; ARTICLE; CHINESE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DIABETIC FOOT; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; RISK FACTOR; UNIVERSITY HOSPITAL;

EID: 84988711921     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2016/8029340     Document Type: Article

References (32)

1. W. Deng, S. Qiu, G. Yang, and B. Chen, "Exenatide onceweekly injection for the treatment of type 2 diabetes in Chinese patients: current perspectives," Therapeutics and Clinical Risk Management, vol. 11, pp. 1153-1162, 2015
2. D. G. Armstrong and L. A. Lavery, "Diabetic foot ulcers: prevention, diagnosis and classification," American Family Physician, vol. 57, no. 6, pp. 1325-1338, 1998
3. G. H. Skrepnek, J. L. Mills, and D. G. Armstrong, "A diabetic emergency one million feet long: disparities and burdens of illness among diabetic foot ulcer cases within emergency departments in the United States, 2006-2010," PLoS ONE, vol. 10, no. 8, Article ID 134914, 2015
4. K. Papatheodorou, M. Banach, M. Edmonds, N. Papanas, and D. Papazoglou, "Complications of diabetes," Journal of Diabetes Research, vol. 2015, Article ID 189525, 5 pages, 2015
5. K. Nirantharakumar, M. Saeed, I. Wilson, T. Marshall, and J. J. Coleman, "In-hospital mortality and length of stay in patients with diabetes having foot disease," Journal of Diabetes and Its Complications, vol. 27, no. 5, pp. 454-458, 2013
6. S. Morbach, H. Furchert, U. Gröblinghoff et al. , "Long-term prognosis of diabetic foot patients and their limbs: amputation and death over the course of a decade," Diabetes Care, vol. 35, no. 10, pp. 2021-2027, 2012
7. A. S. Krolewski, J. H. Warram, C. Forsblom et al. , "Serum concentration of cystatin C and risk of end-stage renal disease in diabetes," Diabetes Care, vol. 35, no. 11, pp. 2311-2316, 2012
8. F. Liu, J. Shen, J. Zhao et al. , "Cystatin C: a strong marker for lower limb ischemia in Chinese type 2 diabetic patients" PLoS ONE, vol. 8, no. 7,Article ID e66907, 2013
9. Y. Hu, F. Liu, J. Shen et al. , "Association between serum cystatin C and diabetic peripheral neuropathy: a cross-sectional study of a Chinese type 2 diabetic population," European Journal of Endocrinology, vol. 171, no. 5, pp. 641-648, 2014
10. W. Deng, X. Dong, Y. Zhang et al. , "Transcutaneous oxygen pressure (TcPO2): a novel diagnostic tool for peripheral neuropathy in type 2 diabetes patients," Diabetes Research and Clinical Practice, vol. 105, no. 3, pp. 336-343, 2014
11. American Diabetes Association, "Standards of medical care in diabetes-2010," Diabetes Care, vol. 33, supplement 1, pp. S11-S61, 2010
12. W. J. Jeffcoate, R. M. Macfarlane, and E. M. Fletcher, "The description and classification of diabetic foot lesions," Diabetic Medicine, vol. 10, no. 7, pp. 676-679, 1993
13. L. X. Zhan, B. C. Branco, D. G. Armstrong, and J. L. Mills Sr. , "The Society for Vascular Surgery lower extremity threatened limb classification system based onWound, Ischemia, and foot Infection (WIfI) correlates with risk of major amputation and time to wound healing," Journal of Vascular Surgery, vol. 61, no. 4, pp. 939-944, 2015
14. F. W. Wagner Jr. , "The dysvascular foot: a system for diagnosis and treatment," Foot and Ankle, vol. 2, no. 2, pp. 64-122, 1981
15. World Health Organization, "International Society of Hypertension Guidelines for the Management of Hypertension," Journal of Hypertension, vol. 17, no. 2, pp. 151-183, 1999
16. C. Bruun, V. Siersma, A. D. Guassora, P. Holstein, and N. de Fine Olivarius, "Amputations and foot ulcers in patients newly diagnosed with type 2 diabetes mellitus and observed for 19 years. The role of age, gender and co-morbidity," Diabetic Medicine, vol. 30, no. 8, pp. 964-972, 2013
17. K. Al-Rubeaan, M. Al Derwish, S. Ouizi et al. , "Diabetic foot complications and their risk factors from a large retrospective cohort study," PLoS ONE, vol. 10, no. 5, Article ID e0124446, 2015
18. E. Pei, J. Li, C. Lu et al. , "Effects of lipids and lipoproteins on diabetic foot in people with type 2 diabetes mellitus: a metaanalysis," Journal of Diabetes and Its Complications, vol. 28, no. 4, pp. 559-564, 2014
19. Y. Yang, T. Østbye, S. B. Tan, Z.-H. Abdul Salam, K. S. Yang, and B. C. Ong, "Risk factors for lower extremity amputation among patients with diabetes in Singapore," Journal of Diabetes and Its Complications, vol. 25, no. 6, pp. 382-386, 2011
20. D. J. Margolis, O. Hofstad, and H. I. Feldman, "Association between renal failure and foot ulcer or lower-extremity amputation in patients with diabetes," Diabetes Care, vol. 31, no. 7, pp. 1331-1336, 2008
21. A. S. Levey, C. Becker, and L. A. Inker, "Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review," The Journal of the American Medical Association, vol. 313, no. 8, pp. 837-846, 2015
22. Y. Ogawa, T. Goto, N. Tamasawa et al. , "Serum cystatin C in diabetic patients. Not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy," Diabetes Research and Clinical Practice, vol. 79, no. 2, pp. 357-361, 2008
23. S.-H. Lee, S.-A. Park, S.-H. Ko et al. , "Insulin resistance and inflammation may have an additional role in the link between cystatin C and cardiovascular disease in type 2 diabetes mellitus patients," Metabolism, vol. 59, no. 2, pp. 241-246, 2010
24. J. R. Brownrigg, R. J. Hinchliffe, J. Apelqvist et al. , "Performance of prognostic markers in the prediction of wound healing or amputation among patients with foot ulcers in diabetes: a systematic review," Diabetes/Metabolism Research and Reviews, vol. 32, supplement 1, pp. 128-135, 2016
25. J. Arpegard, J. Östergren, U. de Faire, L.-O. Hansson, and P. Svensson, "Cystatin C-A marker of peripheral atherosclerotic disease" Atherosclerosis, vol. 199, no. 2, pp. 397-401, 2008
26. H. Yang, C. Wang, M. Guo, Y. Zhou, Z. Feng, and Z. Yin, "Correlations between peroxisome proliferator activator receptor, Cystatin C, or advanced oxidation protein product, and atherosclerosis in diabetes patients," Pathology Research and Practice, vol. 211, no. 3, pp. 235-239, 2015
27. Y. Zhang, Q. Guan, and X. Jin, "Platelet-derived miR-92a downregulates cysteine protease inhibitor cystatin C in type II diabetic lower limb ischemia," Experimental and Therapeutic Medicine, vol. 9, no. 6, pp. 2257-2262, 2015
28. T. C. Powell, J. P. Donnelly, O. M. Gutiérrez, R. L. Griffin, M. M. Safford, and H. E. Wang, "Cystatin C and long term risk of community-acquired sepsis: a population-based cohort study Epidemiology and Health Outcomes," BMC Nephrology, vol. 16, article 61, 2015
29. L. S. Dalrymple, R. Katz, B. Kestenbaum et al. , "The risk of infection-related hospitalization with decreased kidney function," American Journal of Kidney Diseases, vol. 59, no. 3, pp. 356-363, 2012
30. E. J. Lew, J. L. Mills, and D. G. Armstrong, "The deteriorating DFU: prioritising risk factors to avoid amputation," Journal of Wound Care, vol. 24, supplement 2, pp. 31-37, 2015
31. M. G. Shlipak, R. Katz, M. Cushman et al. , "Cystatin-C and inflammatory markers in the ambulatory elderly," American Journal of Medicine, vol. 118, no. 12, pp. 1416. e25-1416. e31, 2005
32. A. A. Evangelopoulos, N. G. V. Vallianou, V. Bountziouka et al. , "Association between serum cystatin C, monocytes and other inflammatory markers," Internal Medicine Journal, vol. 42, no. 5, pp. 517-522, 2012.